Capital Flow Monitor · Sponsors · CIK 2007993
Reunion Neuroscience, Inc.
1 HIGH STREET COURT, MORRISTOWN, NJ, 07960 · 888-880-7386
Pharmaceuticals · Corporation· inc. DELAWARE true 2023
Fit score
—
Offering
$119.9M
Sold
$119.9M
% sold
100.0%
Investors
9
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-09-09 | D/A ·current | 506(b) | $119.9M | $119.9M | 100.0% | 9 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Gregory Mayes — Executive Officer / Director, Morristown, NJ
- Edward Smith — Executive Officer, Morristown, NJ
- Nathan Bryson — Executive Officer, Morristown, NJ
- Mark Pollack — Executive Officer, Morristown, NJ
- Mark Theeuwes — Executive Officer, Morristown, NJ
- Ansbert Gadicke — Director, Morristown, NJ
- Michael Ehlers — Director, Morristown, NJ
-
Alon Lazarus — Director, Morristown, NJ
1 other raise
- Crossbow Therapeutics, Inc. $30.3M of $80.0M · 37.8%
- Ellen Lubman — Director, Morristown, NJ
- Natalie Sacks — Director, Morristown, NJ
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.